Feed / DXCM

DexCom, Inc.

DXCM

Healthcare · 92.35 +2.4% today

Partial group confirmationMarket checked 21 Aug, 15:55 GMT-4

Jodie situation report

DexCom, Inc.'s move is being confirmed by its market group.

DXCM accounts for 15.1% of the group's measured movement across 9.8 effective names. raw member direction is mixed; 10 of 12 session-normalized paths align to the upside. Capital-flow agreement is 21%, so confirmation is not yet clean. No verified headline preceded the measured group move.

MOVE ANATOMY

Is this move genuinely shared?

Session-normalized 5m paths
Role in the moveAligned contributor#1 of 12 by movement share
Group movement share15.1%Absolute path energy—not portfolio weight
Relative path+2.91%aligned
Effective breadth9.8 / 12broad
Relative alignment10/12upside path · 1 counter-moving
Capital-flow agreement21%not yet clean
SEQUENCE READ

DXCM was the first measured mover. DXCM crossed its material path threshold at 10:15 ET. BDX, ABT, ISRG followed.

EVIDENCE COVERAGE

9 of 18 members in Medical Devices & Supplies are active. 0 of 6 disclosed connections are confirming.

What would change this read
  • At least 12 of 18 durable members become active together.
  • Capital-flow agreement rises above 55%.
  • A filing-linked outsider such as AVNS begins moving with the group.

Invalidation: The live read weakens if participation falls to 6 of 18 members or fewer.

Watch this read

Who this business touches

The relationships behind DXCM

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

ABTAbbott LaboratoriescompetitorFeb 12, 2026 ▾

“In selling our current CGM systems, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc’s Diabetes Group (which implemented a spinoff of its diabetes business into a separate company called MiniMed); Roche Diabetes Care,…”

Depended on by

BBNXBeta Bionics, Inc.partnerApr 21, 2026 ▾

“We have also partnered with Dexcom and Abbott—global leaders in popular and easy to use iCGM technology—to integrate the iLet with the Dexcom G6 and G7 iCGMs and with Abbott’s FreeStyle Libre 3 Plus Continuous Glucose Monitor (CGM) sensor.”

Filing peers

No filing peers are available for this name yet.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

DXCM is currently a Participant in the organic co-movement group Medical Devices & Supplies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.